expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Completed a Private Placement of $1.5 Million   RAMAT GAN, ISRAEL, Aug. 14, 2024 (GLOBE NEWSWIRE) -- August 14, 2024, XTL Biopharmaceuticals Ltd. (the "Company" or "XTL") announced today it has completed the acquisition of THE SOCIAL PROXY Ltd. (the "Social Proxy"), an AI web data company, developing and powering a unique ethical, IP based, proxy and data extraction platform for AI and BI Applications at scale (the "Purchase Agreement"). Pursuant to the Purchase Agreement, XTL acquired all of the issued and outstand

6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)

6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)

6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)

6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)

6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)

6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)

6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)

6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)

6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)

20-F - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)

expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Completed a Private Placement of $1.5 Million   RAMAT GAN, ISRAEL, Aug. 14, 2024 (GLOBE NEWSWIRE) -- August 14, 2024, XTL Biopharmaceuticals Ltd. (the "Company" or "XTL") announced today it has completed the acquisition of THE SOCIAL PROXY Ltd. (the "Social Proxy"), an AI web data company, developing and powering a unique ethical, IP based, proxy and data extraction platform for AI and BI Applications at scale (the "Purchase Agreement"). Pursuant to the Purchase Agreement, XTL acquired all of the issued and outstand

expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a Private Placement RAMAT GAN, ISRAEL, June 05, 2024 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (the "Company" or  "XTL") announced today it has entered into a definitive share purchase agreement with the current shareholders of THE SOCIAL PROXY Ltd. (the "Social Proxy"), an AI web data company, developing and powering a unique ethical, IP based, proxy and data extraction platform for AI and BI Applications at scale (the "Purchase Agreement"). Pursuant to the Purchase Agreement

expands its IP portfolio to AI Web Data The Social Proxy is a web data AI companydeveloping and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a Private Placement RAMAT GAN, ISRAEL, March 20, 2024 (GLOBE NEWSWIRE) --  XTL Biopharmaceuticals Ltd. (the "Company" or "XTL") announced today that it has entered into a binding term sheet with THE SOCIAL PROXY Ltd., (the "Social Proxy") a cutting edge web data company, developing and powering a unique ethical, IP based, proxy and data extraction platform for AI & BI Applications at scale (the "Term Sheet"). Pursuant to the Term Sheet, the Company will acquire all of the issued and outsta

Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB, TASE: XTLB.TA))) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets consists of an IP portfolio relating to hCDR1 for the treatment of systemic lupus erythematosus, or SLE, and Sjögren's syndrome, or SS, today announced that the Company received a written notification (the "Notice") from the Nasdaq Stock Market LLC ("Nasdaq") on October 18, 2023, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Rules for continued listing on the Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires listed securitie

Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB, TASE: XTLB.TA))) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets consists of an IP portfolio relating to hCDR1 for the treatment of systemic lupus erythematosus, or SLE, and Sjögren's syndrome, or SS, today addressed the status of the Company's continued and uninterrupted activity in Israel against the background of the recent severe terrorist attack in the south of the country and the subsequent declaration of war by the Israeli government against the Hamas terrorist organization. XTL's management confirms that to date the Company has not seen any

JERUSALEM, Sept. 20, 2021 /PRNewswire/ -- Dr. Morris C. Laster today announced that he has filed preliminary proxy materials with the Securities and Exchange Commission ("SEC") in connection with the 2021 Annual Meeting of Stockholders ("Annual Meeting") of Scopus BioPharma Inc. (NASDAQ:SCPS) ("Scopus" or the "Company") scheduled for October 8, 2021.  Dr. Laster, together with the other participants in his solicitation, own approximately 33.2% of the outstanding shares of the Company's common stock.  Dr. Laster has nominated two highly-qualified individuals – Mordechai Saar Hacham and Joshua Levine (the "Director Nominees") – for election to the Board at the Annual Meeting. "It is clear to m

Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endpoint. Takeda Pharmaceutical Co Ltd (NYSE:TAK) announced topline data from its SKYLINE and SKYWAY Phase 3 studies of Soticlestat (TAK-935) for the treatment of Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS). AMMO shares dipped 19.1% to $2.0306 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Interactive Strength Inc. (NASDAQ:TRNR) shares climbed 148% to $7.07 after dipping 19% on Friday. Mustang Bio, Inc. (NASDAQ:MBIO) shares jumped 145% to $0.32 after the company announced safety and efficacy da

Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) rose sharply in today's pre-market trading after the company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed refractory chronic lymphocytic leukemia. Nurix Therapeutics shares jumped 12.1% to $17.01 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) rose 89.4% to $6.61 in pre-market trading after surging 24% on Friday. Scinai Immunotherapeutics, last week, received a non-binding Letter of Intent from the European Investment Bank for converting loan into equity. Interactive Strength Inc. (NASDAQ:TR

Gainers SINTX Techs (NASDAQ:SINT) shares increased by 22.2% to $0.16 during Wednesday's after-market session. The company's market cap stands at $19.1 million. As per the news, the Q1 earnings report came out 2 days ago. Petros Pharma (NASDAQ:PTPI) shares rose 12.85% to $0.58. The market value of their outstanding shares is at $4.0 million. Bluejay Diagnostics (NASDAQ:BJDX) shares increased by 10.22% to $0.58. The market value of their outstanding shares is at $1.5 million. INVO Bioscience (NASDAQ:INVO) stock rose 7.47% to $1.15. The market value of their outstanding shares is at $4.3 million. Scorpius Holdings (AMEX:SCPX) shares moved upwards by 7.2% to $0.08. The market value of their

Gainers Aethlon Medical (NASDAQ:AEMD) stock moved upwards by 129.0% to $2.7 during Friday's pre-market session. The company's market cap stands at $7.1 million. Novavax (NASDAQ:NVAX) shares rose 119.23% to $9.8. The market value of their outstanding shares is at $1.3 billion. The company's, Q1 earnings came out today. Sensus Healthcare (NASDAQ:SRTS) stock moved upwards by 51.18% to $5.76. The company's market cap stands at $94.4 million. As per the news, the Q1 earnings report came out yesterday. Natera (NASDAQ:NTRA) shares moved upwards by 20.31% to $114.96. The market value of their outstanding shares is at $14.0 billion. The company's, Q1 earnings came out yesterday. XTL Biopharmaceu

Gainers Deciphera Pharmaceuticals (NASDAQ:DCPH) stock rose 71.0% to $25.05 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 billion. Koninklijke Philips (NYSE:PHG) shares moved upwards by 40.91% to $29.69. The company's market cap stands at $26.9 billion. The company's, Q1 earnings came out today. Akanda (NASDAQ:AKAN) shares moved upwards by 25.63% to $0.13. The company's market cap stands at $1.5 million. XTL Biopharmaceuticals (NASDAQ:XTLB) shares rose 22.62% to $2.97. The market value of their outstanding shares is at $16.1 million. Scorpius Holdings (AMEX:SCPX) shares increased by 22.6% to $0.21. The company's market cap stands at $7.4 mill

Gainers Stoke Therapeutics (NASDAQ:STOK) shares increased by 46.1% to $15.03 during Wednesday's regular session. The company's market cap stands at $671.1 million. As per the press release, Q4 earnings came out 2 days ago. Lixte Biotechnology (NASDAQ:LIXT) shares rose 43.68% to $3.24. The company's market cap stands at $7.2 million. Nuvation Bio (NYSE:NUVB) shares moved upwards by 35.41% to $3.9. The company's market cap stands at $854.2 million. Ontrak (NASDAQ:OTRK) shares moved upwards by 29.18% to $0.55. The market value of their outstanding shares is at $15.2 million. PAVmed (NASDAQ:PAVM) stock increased by 25.72% to $2.59. The market value of their outstanding shares is at $20.8 mi

Shares of Landos Biopharma, Inc. (NASDAQ:LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE:ABBV) and Landos Biopharma, reported a definitive agreement under which AbbVie will acquire Landos. Landos Biopharma shares jumped 171.2% to $21.70 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Next.e.GO N.V. (NASDAQ:EGOX) shares jumped 85.8% to $0.0730 after falling around 22% on Friday. Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares climbed 70.1% to $2.9255 after the company announced a collaboration with Univercells Group on nanoparticle-delivered mRNA vaccines. MicroAlgo Inc. (NASDAQ:MLGO) climbed 34.3% to $5.40 a

Gainers Landos Biopharma (NASDAQ:LABP) shares rose 173.9% to $21.45 during Monday's regular session. The market value of their outstanding shares is at $66.8 million. The company's, Q4 earnings came out 2 days ago. Altamira Therapeutics (NASDAQ:CYTO) stock moved upwards by 30.63% to $2.26. The market value of their outstanding shares is at $4.1 million. XTL Biopharmaceuticals (NASDAQ:XTLB) shares increased by 28.24% to $3.36. The company's market cap stands at $18.3 million. Nkarta (NASDAQ:NKTX) shares moved upwards by 23.87% to $11.05. The company's market cap stands at $542.2 million. As per the news, the Q4 earnings report came out 2 days ago. Sagimet Biosciences (NASDAQ:SGMT) stock

Gainers XTL Biopharmaceuticals (NASDAQ:XTLB) shares moved upwards by 13.9% to $2.71 during Wednesday's after-market session. The market value of their outstanding shares is at $14.7 million. Leap Therapeutics (NASDAQ:LPTX) shares rose 11.21% to $2.84. The market value of their outstanding shares is at $72.6 million. As per the press release, Q4 earnings came out 2 days ago. Jaguar Health (NASDAQ:JAGX) stock rose 10.94% to $0.09. The company's market cap stands at $18.2 million. Sharps Technology (NASDAQ:STSS) shares moved upwards by 9.73% to $0.37. The market value of their outstanding shares is at $5.6 million. Universe Pharmaceuticals (NASDAQ:UPC) shares rose 8.88% to $1.96. The compa